The FDA has approved the first generic versions of Johnson & Johnson's big-selling anticoagulant Xarelto, which brought in nearly $2.4 billion in US sales last year. The US regulator has cleared 2.5mg ...
In another move designed to reduce the US' reliance on imported medicines, the FDA has launched a pilot of fast-track reviews for generics tested and made in domestic facilities. According to the ...
Launched in 2017 as a challenger to React Native, Flutter has grown in popularity since, and now has a slightly greater share ...
Two solid-value approaches, one well-built ETF. Our research team assigns Gold ratings to strategies that they have the most conviction will outperform their Morningstar Category average over a market ...
Java 27 is now available, enabling G1 as the default garbage collector everywhere and bringing Compact Object Headers, TLS ...